These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 18789019)

  • 1. [Possibilities of the use of ivabradine in complex therapy acute coronary syndrome].
    Tereshchenko SN; Kositsyna IV; Golubev AV
    Kardiologiia; 2008; 48(7):10-3. PubMed ID: 18789019
    [No Abstract]   [Full Text] [Related]  

  • 2. [The predictors of myocardial electrical instability after its infarction and thrombolytic therapy].
    Chernetsov VA
    Voen Med Zh; 2000 Mar; 321(3):27-31. PubMed ID: 10815535
    [No Abstract]   [Full Text] [Related]  

  • 3. Elderly patients should not be denied fibrinolytic therapy.
    Wong CK; White HD
    Nat Clin Pract Cardiovasc Med; 2007 Oct; 4(10):520-1. PubMed ID: 17724481
    [No Abstract]   [Full Text] [Related]  

  • 4. [Peculiarities of the course of myocardial infarction in young patients with essential arterial hypertension].
    Bazina IB; Alisina NA; Gavrilova OE
    Kardiologiia; 2007; 47(6):56-7. PubMed ID: 18260878
    [No Abstract]   [Full Text] [Related]  

  • 5. Clots kill: hematologic pharmacology for ST-segment elevation myocardial infarction.
    James SH
    Crit Care Nurse; 2012 Dec; 32(6):35-41. PubMed ID: 23203953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of mortality with years of education in patients with ST-segment elevation myocardial infarction treated with fibrinolysis.
    Mehta RH; O'Shea JC; Stebbins AL; Granger CB; Armstrong PW; White HD; Topol EJ; Califf RM; Ohman EM
    J Am Coll Cardiol; 2011 Jan; 57(2):138-46. PubMed ID: 21211684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serial snapshot electrocardiograms and continuous 12-lead ST-segment electrocardiographic monitoring for the prediction of intravenous thrombolysis outcome in patients with ST-segment elevation myocardial infarction.
    Foussas SG; Zairis MN; Tsiaousis GZ; Georgilas AT; Patsourakos NG; Kontos CF; Prodromitou M; Batika PC; Mytas DZ; Adamopoulou EN; Handanis SM; Argyrakis SK
    Int J Cardiol; 2010 Sep; 144(1):169-70. PubMed ID: 19178963
    [No Abstract]   [Full Text] [Related]  

  • 8. Thrombolysis In Myocardial Infarction Frame Count in Takotsubo Cardiomyopathy.
    Khalid N; Iqbal I; Coram R; Raza T; Fahsah I; Ikram S
    Int J Cardiol; 2015 Jul; 191():107-8. PubMed ID: 25965614
    [No Abstract]   [Full Text] [Related]  

  • 9. Facilitation of thrombolysis in acute myocardial infarction.
    Gambhir DS
    Indian Heart J; 1999; 51(5):486-8. PubMed ID: 10721636
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of myocardial infarction with ST-segment elevation].
    Mohácsi A; Edes I; Czuriga I
    Orv Hetil; 2004 Feb; 145(6):297-300. PubMed ID: 15038323
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of ivabradine on left ventricular remodelling after reperfused myocardial infarction: A pilot study.
    Gerbaud E; Montaudon M; Chasseriaud W; Gilbert S; Cochet H; Pucheu Y; Horovitz A; Bonnet J; Douard H; Coste P
    Arch Cardiovasc Dis; 2014 Jan; 107(1):33-41. PubMed ID: 24440004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The complex issue of TIMI frame count in patients with Takotsubo syndrome.
    Madias JE
    Int J Cardiol; 2015 Sep; 194():65. PubMed ID: 26011267
    [No Abstract]   [Full Text] [Related]  

  • 13. Thrombolytic therapy for acute myocardial infarction in unsuspected infective endocarditis.
    Ortega-Carnicer J; Ruiz-Lorenzo F; Benedicto A
    Int J Cardiol; 2005 Aug; 103(1):108-10. PubMed ID: 16061133
    [No Abstract]   [Full Text] [Related]  

  • 14. ST-elevation myocardial infarction: thrombus burden and prognosis.
    Conti CR
    Clin Cardiol; 2008 Jan; 31(1):3-5. PubMed ID: 18203114
    [No Abstract]   [Full Text] [Related]  

  • 15. Fibrinolytic therapy in patients 75 years and older with ST-segment-elevation myocardial infarction: one-year follow-up of a large prospective cohort.
    Stenestrand U; Wallentin L;
    Arch Intern Med; 2003 Apr; 163(8):965-71. PubMed ID: 12719207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Type of Thrombolytic Agent and Rate of Acute Kidney Injury in Patients With Myocardial Infarction].
    Menzorov MV; Shutov AM; Serov VA; Saenko IuV; Grishen'kin LIu
    Kardiologiia; 2015; 55(2):16-20. PubMed ID: 26164983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Reperfusion after acute myocardial infarct with fibrinolytic therapy o combination reduced fibrinolytic therapy and a glycoprotein IIb/IIIa inhibitor: the GUSTO V study].
    Franzosi MG
    Ital Heart J Suppl; 2001 Sep; 2(9):1034-6. PubMed ID: 11675828
    [No Abstract]   [Full Text] [Related]  

  • 18. [Thrombolytic therapy of myocardial infarct. Status after GISSI-2 and ISIS-3].
    Gulba DC; Claus G
    Internist (Berl); 1992 Apr; 33(4):206-15. PubMed ID: 1612844
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy. GUSTO-I investigators.
    Weaver WD; White HD; Wilcox RG; Aylward PE; Morris D; Guerci A; Ohman EM; Barbash GI; Betriu A; Sadowski Z; Topol EJ; Califf RM
    JAMA; 1996 Mar; 275(10):777-82. PubMed ID: 8598594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Strategic Reperfusion Early After Myocardial Infarction (STREAM) study.
    Armstrong PW; Gershlick A; Goldstein P; Wilcox R; Danays T; Bluhmki E; Van de Werf F;
    Am Heart J; 2010 Jul; 160(1):30-35.e1. PubMed ID: 20598969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.